Molecular Templates, Inc.
MTEM
MTEM was delisted on the 24th of December, 2024.
83 hedge funds and large institutions have $91.3M invested in Molecular Templates, Inc. in 2014 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 29 reducing their positions, and 18 closing their positions.
343% more call options, than puts
Call options by funds: $1.29M | Put options by funds: $291K
7% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 29
10% less funds holding
Funds holding: 92 → 83 (-9)
22% less capital invested
Capital invested by funds: $117M → $91.3M (-$25.8M)
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Axa
Paris,
France
|
+$1.26M |
| 2 |
First Eagle Investment Management
New York
|
+$866K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$623K |
| 4 |
Renaissance Technologies
New York
|
+$415K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$365K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$5.64M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.76M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$1.16M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.06M |
| 5 |
HCM
Highbridge Capital Management
New York
|
-$731K |
MTEM Hedge Fund Activity: Q4 2014 in Review
83 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q4 2014, worth a combined $91.3M — down 22% from $117M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of MTEM and 10 opened new positions — a net loss of 8 holders — while 29 trimmed existing stakes and 27 added.
The largest buyer was Axa, adding an estimated $1.26M. The largest seller was JP Morgan Chase, cutting an estimated $5.64M.
- 83 institutional investors held Molecular Templates, Inc. (MTEM) as of Q4 2014, down from 92 in Q3 2014.
- Funds reported $91.3M of Molecular Templates, Inc. stock for Q4 2014, down 22% quarter-over-quarter.
- 10 funds opened new Molecular Templates, Inc. positions in Q4 2014 and 18 closed out, a net change of -8 holders.
- The largest Molecular Templates, Inc. buyer in Q4 2014 was Axa, an estimated $1.26M added.
- The largest Molecular Templates, Inc. seller in Q4 2014 was JP Morgan Chase, an estimated $5.64M sold.
Based on aggregated 13F filings for Q4 2014.